 | • レポートコード：MRC2012B0507 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ヒトマイクロバイオームの世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒトマイクロバイオームの種類別市場規模（消化管ヒトミコビオーム、泌尿生殖器ヒトミコビオーム、その他）、用途別市場規模（治療、診断）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Vedanta、4D Pharma Research Ltd、Rebiotix、Seres Therapeutics、AvidBiotics、Second Genome、Metabogen、Enterome BioScience、ActoGeniX、Enterologics、Miomics、Metabiomics、Symbiotix Biotherapies、Symberix、Ritter Pharmaceuticals、MicroBiome Therapeutics LLC、Osel、 ・地域別グローバル市場分析 2015年-2020年 ・ヒトマイクロバイオームの北米市場（アメリカ、カナダ、メキシコ） ・ヒトマイクロバイオームのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ヒトマイクロバイオームのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ヒトマイクロバイオームの南米市場（ブラジル、アルゼンチン） ・ヒトマイクロバイオームの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：消化管ヒトミコビオーム、泌尿生殖器ヒトミコビオーム、その他 ・用途別分析：治療、診断 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Human Microbiome market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Human Microbiome market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 20.0%% in the forecast period of 2020 to 2025 and will expected to reach USD 590 million by 2025, from USD 284.5 million in 2019.
Market segmentation
Human Microbiome market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Human Microbiome market has been segmented into:
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Other
By Application, Human Microbiome has been segmented into:
Treatment
Diagnosis
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Microbiome market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Microbiome markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Microbiome market.
The report offers in-depth assessment of the growth and other aspects of the Human Microbiome market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Human Microbiome Market Share Analysis
Human Microbiome competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Microbiome sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Microbiome sales, revenue and market share for each player covered in this report.
The major players covered in Human Microbiome are:
Vedanta
4D Pharma Research Ltd
Rebiotix
Seres Therapeutics
AvidBiotics
Second Genome
Metabogen
Enterome BioScience
ActoGeniX
Enterologics
Miomics
Metabiomics
Symbiotix Biotherapies
Symberix
Ritter Pharmaceuticals
MicroBiome Therapeutics LLC
Osel
Among other players domestic and global, Human Microbiome market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Human Microbiome Market Overview
1.1 Product Overview and Scope of Human Microbiome
1.2 Classification of Human Microbiome by Type
1.2.1 Global Human Microbiome Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Human Microbiome Revenue Market Share by Type in 2019
1.2.3 Gastrointestinal Tract Human Micobiome
1.2.4 Urogenital Tract Human Micobiome
1.2.5 Other
1.3 Global Human Microbiome Market by Application
1.3.1 Overview: Global Human Microbiome Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Treatment
1.3.3 Diagnosis
1.4 Global Human Microbiome Market by Regions
1.4.1 Global Human Microbiome Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Human Microbiome (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Human Microbiome Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Human Microbiome Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Microbiome Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Human Microbiome Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Microbiome Status and Prospect (2015-2025)
2 Company Profiles
2.1 Vedanta
2.1.1 Vedanta Details
2.1.2 Vedanta Major Business
2.1.3 Vedanta SWOT Analysis
2.1.4 Vedanta Product and Services
2.1.5 Vedanta Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.2 4D Pharma Research Ltd
2.2.1 4D Pharma Research Ltd Details
2.2.2 4D Pharma Research Ltd Major Business
2.2.3 4D Pharma Research Ltd SWOT Analysis
2.2.4 4D Pharma Research Ltd Product and Services
2.2.5 4D Pharma Research Ltd Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.3 Rebiotix
2.3.1 Rebiotix Details
2.3.2 Rebiotix Major Business
2.3.3 Rebiotix SWOT Analysis
2.3.4 Rebiotix Product and Services
2.3.5 Rebiotix Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.4 Seres Therapeutics
2.4.1 Seres Therapeutics Details
2.4.2 Seres Therapeutics Major Business
2.4.3 Seres Therapeutics SWOT Analysis
2.4.4 Seres Therapeutics Product and Services
2.4.5 Seres Therapeutics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.5 AvidBiotics
2.5.1 AvidBiotics Details
2.5.2 AvidBiotics Major Business
2.5.3 AvidBiotics SWOT Analysis
2.5.4 AvidBiotics Product and Services
2.5.5 AvidBiotics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.6 Second Genome
2.6.1 Second Genome Details
2.6.2 Second Genome Major Business
2.6.3 Second Genome Product and Services
2.6.4 Second Genome Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.7 Metabogen
2.7.1 Metabogen Details
2.7.2 Metabogen Major Business
2.7.3 Metabogen Product and Services
2.7.4 Metabogen Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.8 Enterome BioScience
2.8.1 Enterome BioScience Details
2.8.2 Enterome BioScience Major Business
2.8.3 Enterome BioScience Product and Services
2.8.4 Enterome BioScience Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.9 ActoGeniX
2.9.1 ActoGeniX Details
2.9.2 ActoGeniX Major Business
2.9.3 ActoGeniX Product and Services
2.9.4 ActoGeniX Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.10 Enterologics
2.10.1 Enterologics Details
2.10.2 Enterologics Major Business
2.10.3 Enterologics Product and Services
2.10.4 Enterologics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.11 Miomics
2.11.1 Miomics Details
2.11.2 Miomics Major Business
2.11.3 Miomics Product and Services
2.11.4 Miomics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.12 Metabiomics
2.12.1 Metabiomics Details
2.12.2 Metabiomics Major Business
2.12.3 Metabiomics Product and Services
2.12.4 Metabiomics Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.13 Symbiotix Biotherapies
2.13.1 Symbiotix Biotherapies Details
2.13.2 Symbiotix Biotherapies Major Business
2.13.3 Symbiotix Biotherapies Product and Services
2.13.4 Symbiotix Biotherapies Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.14 Symberix
2.14.1 Symberix Details
2.14.2 Symberix Major Business
2.14.3 Symberix Product and Services
2.14.4 Symberix Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.15 Ritter Pharmaceuticals
2.15.1 Ritter Pharmaceuticals Details
2.15.2 Ritter Pharmaceuticals Major Business
2.15.3 Ritter Pharmaceuticals Product and Services
2.15.4 Ritter Pharmaceuticals Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.16 MicroBiome Therapeutics LLC
2.16.1 MicroBiome Therapeutics LLC Details
2.16.2 MicroBiome Therapeutics LLC Major Business
2.16.3 MicroBiome Therapeutics LLC Product and Services
2.16.4 MicroBiome Therapeutics LLC Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
2.17 Osel
2.17.1 Osel Details
2.17.2 Osel Major Business
2.17.3 Osel Product and Services
2.17.4 Osel Human Microbiome Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Human Microbiome Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Microbiome Players Market Share
3.2.2 Top 10 Human Microbiome Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Human Microbiome Revenue and Market Share by Regions
4.2 North America Human Microbiome Revenue and Growth Rate (2015-2020)
4.3 Europe Human Microbiome Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Microbiome Revenue and Growth Rate (2015-2020)
4.5 South America Human Microbiome Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Human Microbiome Revenue and Growth Rate (2015-2020)
5 North America Human Microbiome Revenue by Countries
5.1 North America Human Microbiome Revenue by Countries (2015-2020)
5.2 USA Human Microbiome Revenue and Growth Rate (2015-2020)
5.3 Canada Human Microbiome Revenue and Growth Rate (2015-2020)
5.4 Mexico Human Microbiome Revenue and Growth Rate (2015-2020)
6 Europe Human Microbiome Revenue by Countries
6.1 Europe Human Microbiome Revenue by Countries (2015-2020)
6.2 Germany Human Microbiome Revenue and Growth Rate (2015-2020)
6.3 UK Human Microbiome Revenue and Growth Rate (2015-2020)
6.4 France Human Microbiome Revenue and Growth Rate (2015-2020)
6.5 Russia Human Microbiome Revenue and Growth Rate (2015-2020)
6.6 Italy Human Microbiome Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Human Microbiome Revenue by Countries
7.1 Asia-Pacific Human Microbiome Revenue by Countries (2015-2020)
7.2 China Human Microbiome Revenue and Growth Rate (2015-2020)
7.3 Japan Human Microbiome Revenue and Growth Rate (2015-2020)
7.4 Korea Human Microbiome Revenue and Growth Rate (2015-2020)
7.5 India Human Microbiome Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Human Microbiome Revenue and Growth Rate (2015-2020)
8 South America Human Microbiome Revenue by Countries
8.1 South America Human Microbiome Revenue by Countries (2015-2020)
8.2 Brazil Human Microbiome Revenue and Growth Rate (2015-2020)
8.3 Argentina Human Microbiome Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Human Microbiome by Countries
9.1 Middle East & Africa Human Microbiome Revenue by Countries (2015-2020)
9.2 Saudi Arabia Human Microbiome Revenue and Growth Rate (2015-2020)
9.3 UAE Human Microbiome Revenue and Growth Rate (2015-2020)
9.4 Egypt Human Microbiome Revenue and Growth Rate (2015-2020)
9.5 South Africa Human Microbiome Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Human Microbiome Revenue and Market Share by Type (2015-2020)
10.2 Global Human Microbiome Market Forecast by Type (2019-2024)
10.3 Gastrointestinal Tract Human Micobiome Revenue Growth Rate (2015-2025)
10.4 Urogenital Tract Human Micobiome Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Human Microbiome Market Segment by Application
11.1 Global Human Microbiome Revenue Market Share by Application (2015-2020)
11.2 Human Microbiome Market Forecast by Application (2019-2024)
11.3 Treatment Revenue Growth (2015-2020)
11.4 Diagnosis Revenue Growth (2015-2020)
12 Global Human Microbiome Market Size Forecast (2021-2025)
12.1 Global Human Microbiome Market Size Forecast (2021-2025)
12.2 Global Human Microbiome Market Forecast by Regions (2021-2025)
12.3 North America Human Microbiome Revenue Market Forecast (2021-2025)
12.4 Europe Human Microbiome Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Human Microbiome Revenue Market Forecast (2021-2025)
12.6 South America Human Microbiome Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Human Microbiome Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Human Microbiome Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Microbiome by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Microbiome Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Human Microbiome Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Human Microbiome Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Vedanta Corporate Information, Location and Competitors
Table 7. Vedanta Human Microbiome Major Business
Table 8. Vedanta Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 9. Vedanta SWOT Analysis
Table 10. Vedanta Human Microbiome Product and Solutions
Table 11. Vedanta Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. 4D Pharma Research Ltd Corporate Information, Location and Competitors
Table 13. 4D Pharma Research Ltd Human Microbiome Major Business
Table 14. 4D Pharma Research Ltd Human Microbiome Total Revenue (USD Million) (2018-2019)
Table 15. 4D Pharma Research Ltd SWOT Analysis
Table 16. 4D Pharma Research Ltd Human Microbiome Product and Solutions
Table 17. 4D Pharma Research Ltd Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Rebiotix Corporate Information, Location and Competitors
Table 19. Rebiotix Human Microbiome Major Business
Table 20. Rebiotix Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 21. Rebiotix SWOT Analysis
Table 22. Rebiotix Human Microbiome Product and Solutions
Table 23. Rebiotix Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Seres Therapeutics Corporate Information, Location and Competitors
Table 25. Seres Therapeutics Human Microbiome Major Business
Table 26. Seres Therapeutics Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 27. Seres Therapeutics SWOT Analysis
Table 28. Seres Therapeutics Human Microbiome Product and Solutions
Table 29. Seres Therapeutics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. AvidBiotics Corporate Information, Location and Competitors
Table 31. AvidBiotics Human Microbiome Major Business
Table 32. AvidBiotics Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 33. AvidBiotics SWOT Analysis
Table 34. AvidBiotics Human Microbiome Product and Solutions
Table 35. AvidBiotics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Second Genome Corporate Information, Location and Competitors
Table 37. Second Genome Human Microbiome Major Business
Table 38. Second Genome Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 39. Second Genome SWOT Analysis
Table 40. Second Genome Human Microbiome Product and Solutions
Table 41. Second Genome Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Metabogen Corporate Information, Location and Competitors
Table 43. Metabogen Human Microbiome Major Business
Table 44. Metabogen Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 45. Metabogen SWOT Analysis
Table 46. Metabogen Human Microbiome Product and Solutions
Table 47. Metabogen Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Enterome BioScience Corporate Information, Location and Competitors
Table 49. Enterome BioScience Human Microbiome Major Business
Table 50. Enterome BioScience Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 51. Enterome BioScience SWOT Analysis
Table 52. Enterome BioScience Human Microbiome Product and Solutions
Table 53. Enterome BioScience Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. ActoGeniX Corporate Information, Location and Competitors
Table 55. ActoGeniX Human Microbiome Major Business
Table 56. ActoGeniX Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 57. ActoGeniX SWOT Analysis
Table 58. ActoGeniX Human Microbiome Product and Solutions
Table 59. ActoGeniX Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Enterologics Corporate Information, Location and Competitors
Table 61. Enterologics Human Microbiome Major Business
Table 62. Enterologics Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 63. Enterologics SWOT Analysis
Table 64. Enterologics Human Microbiome Product and Solutions
Table 65. Enterologics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Miomics Corporate Information, Location and Competitors
Table 67. Miomics Human Microbiome Major Business
Table 68. Miomics Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 69. Miomics SWOT Analysis
Table 70. Miomics Human Microbiome Product and Solutions
Table 71. Miomics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Metabiomics Corporate Information, Location and Competitors
Table 73. Metabiomics Human Microbiome Major Business
Table 74. Metabiomics Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 75. Metabiomics SWOT Analysis
Table 76. Metabiomics Human Microbiome Product and Solutions
Table 77. Metabiomics Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Symbiotix Biotherapies Corporate Information, Location and Competitors
Table 79. Symbiotix Biotherapies Human Microbiome Major Business
Table 80. Symbiotix Biotherapies Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 81. Symbiotix Biotherapies SWOT Analysis
Table 82. Symbiotix Biotherapies Human Microbiome Product and Solutions
Table 83. Symbiotix Biotherapies Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Symberix Corporate Information, Location and Competitors
Table 85. Symberix Human Microbiome Major Business
Table 86. Symberix Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 87. Symberix SWOT Analysis
Table 88. Symberix Human Microbiome Product and Solutions
Table 89. Symberix Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Ritter Pharmaceuticals Corporate Information, Location and Competitors
Table 91. Ritter Pharmaceuticals Human Microbiome Major Business
Table 92. Ritter Pharmaceuticals Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 93. Ritter Pharmaceuticals SWOT Analysis
Table 94. Ritter Pharmaceuticals Human Microbiome Product and Solutions
Table 95. Ritter Pharmaceuticals Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. MicroBiome Therapeutics LLC Corporate Information, Location and Competitors
Table 97. MicroBiome Therapeutics LLC Human Microbiome Major Business
Table 98. MicroBiome Therapeutics LLC Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 99. MicroBiome Therapeutics LLC SWOT Analysis
Table 100. MicroBiome Therapeutics LLC Human Microbiome Product and Solutions
Table 101. MicroBiome Therapeutics LLC Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Osel Corporate Information, Location and Competitors
Table 103. Osel Human Microbiome Major Business
Table 104. Osel Human Microbiome Total Revenue (USD Million) (2017-2018)
Table 105. Osel SWOT Analysis
Table 106. Osel Human Microbiome Product and Solutions
Table 107. Osel Human Microbiome Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global Human Microbiome Revenue (Million USD) by Players (2015-2020)
Table 109. Global Human Microbiome Revenue Share by Players (2015-2020)
Table 110. Global Human Microbiome Revenue (Million USD) by Regions (2015-2020)
Table 111. Global Human Microbiome Revenue Market Share by Regions (2015-2020)
Table 112. North America Human Microbiome Revenue by Countries (2015-2020)
Table 113. North America Human Microbiome Revenue Market Share by Countries (2015-2020)
Table 114. Europe Human Microbiome Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific Human Microbiome Revenue (Million USD) by Countries (2015-2020)
Table 116. South America Human Microbiome Revenue by Countries (2015-2020)
Table 117. South America Human Microbiome Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa Human Microbiome Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa Human Microbiome Revenue Market Share by Countries (2015-2020)
Table 120. Global Human Microbiome Revenue (Million USD) by Type (2015-2020)
Table 121. Global Human Microbiome Revenue Share by Type (2015-2020)
Table 122. Global Human Microbiome Revenue Forecast by Type (2021-2025)
Table 123. Global Human Microbiome Revenue by Application (2015-2020)
Table 124. Global Human Microbiome Revenue Share by Application (2015-2020)
Table 125. Global Human Microbiome Revenue Forecast by Application (2021-2025)
Table 126. Global Human Microbiome Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Human Microbiome Picture
Figure 2. Global Human Microbiome Revenue Market Share by Type in 2019
Figure 3. Gastrointestinal Tract Human Micobiome Picture
Figure 4. Urogenital Tract Human Micobiome Picture
Figure 5. Other Picture
Figure 6. Human Microbiome Revenue Market Share by Application in 2019
Figure 7. Treatment Picture
Figure 8. Diagnosis Picture
Figure 9. Global Human Microbiome Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Human Microbiome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Human Microbiome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Human Microbiome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Human Microbiome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Human Microbiome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Human Microbiome Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Human Microbiome Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Human Microbiome Revenue Market Share in 2019
Figure 18. Global Top 10 Players Human Microbiome Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Human Microbiome Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Human Microbiome Revenue Market Share by Regions (2015-2020)
Figure 22. Global Human Microbiome Revenue Market Share by Regions in 2018
Figure 23. North America Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 24. Europe Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 26. South America Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 28. North America Human Microbiome Revenue Market Share by Countries (2015-2020)
Figure 29. North America Human Microbiome Revenue Market Share by Countries in 2019
Figure 30. USA Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 31. Canada Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 33. Europe Human Microbiome Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Human Microbiome Revenue Market Share by Countries in 2019
Figure 35. Germany Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 36. UK Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 37. France Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 38. Russia Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 39. Italy Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Human Microbiome Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Human Microbiome Revenue Market Share by Countries in 2019
Figure 42. China Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 43. Japan Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 44. Korea Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 45. India Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 47. South America Human Microbiome Revenue Market Share by Countries (2015-2020)
Figure 48. South America Human Microbiome Revenue Market Share by Countries in 2019
Figure 49. Brazil Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Human Microbiome Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Human Microbiome Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 54. UAE Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Human Microbiome Revenue and Growth Rate (2015-2020)
Figure 57. Global Human Microbiome Revenue Share by Type (2015-2020)
Figure 58. Global Human Microbiome Revenue Share by Type in 2019
Figure 59. Global Human Microbiome Market Share Forecast by Type (2021-2025)
Figure 60. Global Gastrointestinal Tract Human Micobiome Revenue Growth Rate (2015-2020)
Figure 61. Global Urogenital Tract Human Micobiome Revenue Growth Rate (2015-2020)
Figure 62. Global Other Revenue Growth Rate (2015-2020)
Figure 63. Global Human Microbiome Revenue Share by Application (2015-2020)
Figure 64. Global Human Microbiome Revenue Share by Application in 2019
Figure 65. Global Human Microbiome Market Share Forecast by Application (2021-2025)
Figure 66. Global Treatment Revenue Growth Rate (2015-2020)
Figure 67. Global Diagnosis Revenue Growth Rate (2015-2020)
Figure 68. Global Human Microbiome Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Human Microbiome Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Human Microbiome Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Human Microbiome Revenue Market Forecast (2021-2025)
Figure 72. Europe Human Microbiome Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Human Microbiome Revenue Market Forecast (2021-2025)
Figure 74. South America Human Microbiome Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Human Microbiome Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
ヒトマイクロバイオーム治療薬の世界市場（～2026年） Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Mic…- ヒトマイクロバイオームベース薬剤・診断の世界市場（～2026年） The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness. Rising cases of ch…
- ミクロビオーム医薬品の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Microbiome Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Microbiome Drugs market repo…
- 組換えヒトアルブミンの世界市場（～2026年） Recombinant human albumin (rHA) is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA), to which it is structurally equivalent. Market Analysis and Insights: Global Recombinant Human Albumin Market The global Recombinant Human Albumin ma…
- ヒトパラインフルエンザウイルス（HPIV）診断診断の世界市場（～2026年） Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…